Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

about

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

Item

http://www.wikidata.org/entity/Q58804320

description

scientific article published on 01 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@en

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@nl

type

Item

label

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@en

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@nl

prefLabel

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@en

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@nl

P1476

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans

@en

P2093

Dafne Müller

http://www.w3.org/2001/XMLSchema#string

Friederike Gieseke

http://www.w3.org/2001/XMLSchema#string

Klaus Pfizenmaier

http://www.w3.org/2001/XMLSchema#string

Sina Fellermeier-Kopf

http://www.w3.org/2001/XMLSchema#string

Ugur Sahin

http://www.w3.org/2001/XMLSchema#string

P2860

Principles of antibody-mediated TNF receptor activation

Molecular mechanisms of T cell co-stimulation and co-inhibition

The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.

Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses.

Oncology meets immunology: the cancer-immunity cycle.

Combination cancer immunotherapy and new immunomodulatory targets.

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.

Combination immunotherapy: a road map.

P304

e1471442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2018.1471442

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland E Kontermann

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30228940

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

6140609

http://www.w3.org/2001/XMLSchema#string